Skip to main content
. 2017 Nov 11;62(1):20–38. doi: 10.3164/jcbn.17-62

Table 9.

The modified Rankin Scale scores assessed at discharge within 3 months or at 3 months after onset, in patients treated within 24 h after onset.

Grade 0 1 2 3 4 5 Death
Edaravone (n = 42) 14 10 8 5 2 2 1 p = 0.0001*
Placebo (n = 39) 1 6 13 3 8 4 4

Grade: 0, no symptoms at all; 1, no significant disability despite symptoms; 2, slight disability; 3, moderate disability; 4, moderately severe disability; 5, severe disability. *Wilcoxon’s rank sum test.